Efficiency and the futures market in organs
- PMID:37688713
- DOI: 10.1007/s40592-023-00180-0
Efficiency and the futures market in organs
Abstract
There has been considerable debate over regulated organ markets. Especially current markets, where people sell one of their kidneys while still alive, have received increased attention. Futures markets remain an interesting and under-discussed alternative specification of a market-based solution to the organ shortage. Futures markets pertain to the sale of the right to procure people's organs after they die. There is a wide range of possible specifications of the futures market. There are, however, some major unaddressed efficiency concerns. This article presents this class of concerns and discusses the implication for organ futures markets. It identifies a number of inefficiency sources pertaining to crowding out, bad organs, costs and missed opportunities, family refusals, moral hazard and strength of the provided incentive. However, a complete assessment of futures market requires better knowledge regarding the potential reaction from donors, families and health professionals.
Keywords: Controversial markets; Moral limits of markets; Organ donation; Organ futures markets; Organ markets.
© 2023. The Author(s) under exclusive licence to Monash University.
Similar articles
- If the Price is Right: The Ethics and Efficiency of Market Solutions to the Organ Shortage.Albertsen A.Albertsen A.J Bioeth Inq. 2020 Sep;17(3):357-367. doi: 10.1007/s11673-020-09981-y. Epub 2020 Jun 15.J Bioeth Inq. 2020.PMID:32557218
- Autonomy, moral constraints, and markets in kidneys.Kerstein SJ.Kerstein SJ.J Med Philos. 2009 Dec;34(6):573-85. doi: 10.1093/jmp/jhp046. Epub 2009 Oct 21.J Med Philos. 2009.PMID:19846479
- Markets and the needy: organ sales or aid?Zutlevics TL.Zutlevics TL.J Appl Philos. 2001;18(3):297-302. doi: 10.1111/1468-5930.00196.J Appl Philos. 2001.PMID:11981993
- A "Queen of Hearts" trial of organ markets: why Scheper-Hughes's objections to markets in human organs fail.Taylor JS.Taylor JS.J Med Ethics. 2007 Apr;33(4):201-4. doi: 10.1136/jme.2006.016527.J Med Ethics. 2007.PMID:17400616Free PMC article.Review.
- Assessing the likely harms to kidney vendors in regulated organ markets.Koplin J.Koplin J.Am J Bioeth. 2014;14(10):7-18. doi: 10.1080/15265161.2014.947041.Am J Bioeth. 2014.PMID:25229573Review.
Cited by
- Public Opinions on Removing Disincentives and Introducing Incentives for Organ Donation: Proposing a European Research Agenda.Ambagtsheer F, Bunnik E, Pengel LHM, Reinders ME, Elias JJ, Lacetera N, Macis M.Ambagtsheer F, et al.Transpl Int. 2024 Apr 3;37:12483. doi: 10.3389/ti.2024.12483. eCollection 2024.Transpl Int. 2024.PMID:38644936Free PMC article.
References
- Albertsen, Andreas. 2017. Priority to organ donors: Personal responsibility, equal access and the priority rule in organ procurement. Diamitros 51 (March): 137–152.
- Albertsen, Andreas. 2020. Against the family veto in organ procurement: Why the wishes of the dead should prevail when the living and the deceased disagree on organ donation. Bioethics 34 (3): 272–280.https://doi.org/10.1111/bioe.12661 . - DOI
- Albertsen, Andreas. 2020. If the price is right: The ethics and efficiency of market solutions to the organ shortage. Journal of Bioethical Inquiry 17 (3): 357–367.https://doi.org/10.1007/s11673-020-09981-y . - DOI
- Albertsen, Andreas. 2023a. Organ Markets. In The Rowman & Littlefield Handbook of Bioethics, ed. Ezio Di Nucci, Ji-Young. Lee, and Isaac Eagner, 170–84. Maryland: Rowman & Littlefield.
- Albertsen, Andreas. 2023b. Priority for organ donors in the allocation of organs: Priority rules from the perspective of equality of opportunity. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine 48: 359–372. - DOI
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous